Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases

Retinoblastoma is a malignant tumour of the retina which most often occurs in children. Earlier studies on retinoblastoma have concentrated on the identification of key players in the disease and have not provided information on activated/inhibited signalling pathways. The dysregulation of protein phosphorylation in cancer provides clues about the affected signalling cascades in cancer. Phosphoproteomics is an ideal tool for the study of phosphorylation changes in proteins. Hence, global phosphoproteomics of retinoblastoma (RB) was carried out to identify signalling events associated with this cancer. Over 350 proteins showed differential phosphorylation in RB compared to control retina. Our study identified stress response proteins to be hyperphosphorylated in RB which included H2A histone family member X (H2AFX) and sirtuin 1. In particular, Ser140 of H2AFX also known as gamma-H2AX was found to be hyperphosphorylated in retinoblastoma, which indicated the activation of DNA damage response pathways. We also observed the activation of anti-apoptosis in retinoblastoma compared to control. These observations showed the activation of survival pathways in retinoblastoma. The identification of hyperphosphorylated protein kinases including Bromodomain containing 4 (BRD4), Lysine deficient protein kinase 1 (WNK1), and Cyclin-dependent kinase 1 (CDK1) in RB opens new avenues for the treatment of RB. These kinases can be considered as probable therapeutic targets for RB, as small-molecule inhibitors for some of these kinases are already in clinical trials for the treatment other cancers.

[1]  P. Eyers,et al.  Pseudokinases: update on their functions and evaluation as new drug targets. , 2017, Future medicinal chemistry.

[2]  Shuxing Zhang,et al.  Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor , 2016, Scientific Reports.

[3]  Roger Williams,et al.  Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth. , 2016, Cancer genomics & proteomics.

[4]  Koji Okamoto,et al.  TNIK inhibition abrogates colorectal cancer stemness , 2016, Nature Communications.

[5]  F. White,et al.  Methods for the Analysis of Protein Phosphorylation-Mediated Cellular Signaling Networks. , 2016, Annual review of analytical chemistry.

[6]  Zhenfeng Duan,et al.  The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer , 2016, Oncotarget.

[7]  Rebecca S. Lescarbeau,et al.  Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma , 2016, Molecular Cancer Therapeutics.

[8]  Jianmin Wu,et al.  The kinome 'at large' in cancer , 2016, Nature Reviews Cancer.

[9]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[10]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..

[11]  E. Hanse,et al.  Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas , 2015, Molecular Cancer.

[12]  M. Cobb,et al.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK , 2014, Proceedings of the National Academy of Sciences.

[13]  C. Yuh,et al.  Zebrafish WNK Lysine Deficient Protein Kinase 1 (wnk1) Affects Angiogenesis Associated with VEGF Signaling , 2014, PloS one.

[14]  L. Jensen,et al.  KinomeXplorer: an integrated platform for kinome biology studies , 2014, Nature Methods.

[15]  T. Corson,et al.  The genomic landscape of retinoblastoma: a review , 2014, Clinical & experimental ophthalmology.

[16]  K. Nakayama,et al.  A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. , 2012, Journal of proteome research.

[17]  B. Blagoev,et al.  Quantitative phosphoproteomics to characterize signaling networks. , 2012, Seminars in cell & developmental biology.

[18]  W. Cho,et al.  Phosphoproteomics and Lung Cancer Research , 2012, International journal of molecular sciences.

[19]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[20]  Daniel Schwartz,et al.  Biological sequence motif discovery using motif-x. , 2011, Current protocols in bioinformatics.

[21]  A. Nita-Lazar,et al.  Quantitative analysis of phosphorylation‐based protein signaling networks in the immune system by mass spectrometry , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[22]  Katsuya Ueno,et al.  Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt , 2011, Proceedings of the National Academy of Sciences.

[23]  A. Jimeno,et al.  New phosphatidylinositol 3-kinase inhibitors for cancer , 2011, Expert opinion on investigational drugs.

[24]  H. Kosako,et al.  Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways , 2011, Expert review of proteomics.

[25]  A. Składanowski,et al.  H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy , 2010, Journal of nucleic acids.

[26]  P. Jordan,et al.  Emerging roles for WNK kinases in cancer , 2010, Cellular and Molecular Life Sciences.

[27]  K. Ashman,et al.  Phosphoproteomics and cancer research , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[28]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[29]  Xutong Sun,et al.  Down‐regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration , 2006, Journal of neurochemistry.

[30]  H. Matsuo,et al.  Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions , 2006, Molecular and Cellular Biology.

[31]  G. Shapiro,et al.  Cyclin-dependent kinase pathways as targets for cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Stephanie Schneider,et al.  Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma , 2005, Oncogene.

[33]  J. Ramos,et al.  Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. , 2005, The Biochemical journal.

[34]  Brian B Haab,et al.  Antibody Arrays in Cancer Research , 2005, Molecular & Cellular Proteomics.

[35]  M. Przybylski,et al.  Phosphorylation by Protein Kinase CK2 Changes the DNA Binding Properties of the Human Chromatin Protein DEK , 2004, Molecular and Cellular Biology.

[36]  Baolin Zhang,et al.  Rac1 Inhibits Apoptosis in Human Lymphoma Cells by Stimulating Bad Phosphorylation on Ser-75 , 2004, Molecular and Cellular Biology.

[37]  Peter O. Krutzik,et al.  Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[38]  T. Gardner,et al.  Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy , 2003, Progress in Retinal and Eye Research.

[39]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[40]  Hanno Steen,et al.  Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. , 2002, Trends in biotechnology.

[41]  Philip R. Cohen.  The role of protein phosphorylation in human health and disease.: Delivered on June 30th 2001 at the FEBS Meeting in Lisbon , 2001 .

[42]  P. Cohen.  The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. , 2001, European journal of biochemistry.

[43]  S R Datta,et al.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. , 2000, Molecular cell.

[44]  D. Payan,et al.  TNIK, a Novel Member of the Germinal Center Kinase Family That Activates the c-Jun N-terminal Kinase Pathway and Regulates the Cytoskeleton* , 1999, The Journal of Biological Chemistry.

[45]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[46]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[47]  P. Cohen,et al.  On target with a new mechanism for the regulation of protein phosphorylation. , 1993, Trends in biochemical sciences.